Aurora Cannabis vs Organigram Global
Aurora Cannabis is the larger business, with $232m of revenue in fiscal 2026 against $185m for Organigram Global (1.3 times as much). Organigram Global grew faster (57.8% against 11.7%). Organigram Global kept more of each dollar of sales as profit: a net margin of -9.6% against -42.4%. Aurora Cannabis carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | Aurora CannabisACB, 2026 | Organigram GlobalOGI, 2025 |
|---|---|---|
| Revenue | $232m | $185m |
| Revenue growth | 11.7% | 57.8% |
| Net income | −$98.4m | −$17.7m |
| Operating margin | — | -5.9% |
| Net margin | -42.4% | -9.6% |
| Return on equity | -25.9% | -7.4% |
| Free cash flow | −$9.8m | −$17.6m |
| Cash | $46.4m | $60.0m |
| Total debt | $0 | $17,951 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $295m | $123m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |